Basic, translational and clinical aspects of bronchiectasis in adults

JD Chalmers, S Elborn… - European Respiratory …, 2023 - Eur Respiratory Soc
Bronchiectasis is a common progressive respiratory disease with recognisable radiological
abnormalities and a clinical syndrome of cough, sputum production and recurrent respiratory …

[HTML][HTML] The association between inhaled corticosteroid and the risks of SARS-COV-2 infection: A systematic review and meta-analysis

CH Chen, CY Chen, CC Lai, YH Wang… - Journal of infection and …, 2023 - Elsevier
Background The effect of inhaled corticosteroid (ICS) on the risk of severe acute respiratory
syndrome coronavirus 2 (SARS-COV-2) infection is unclear. Methods We performed a …

Multi-modal molecular determinants of clinically relevant osteoporosis subtypes

C Yuan, XT Yu, J Wang, B Shu, XY Wang, C Huang… - Cell Discovery, 2024 - nature.com
Due to a rapidly aging global population, osteoporosis and the associated risk of bone
fractures have become a wide-spread public health problem. However, osteoporosis is very …

Regulation of bone mass in inflammatory diseases

G Adami - Best Practice & Research Clinical Endocrinology & …, 2022 - Elsevier
Inflammation is among the major determinants of bone loss in chronic disease and aging.
Bone metabolism is radically affected by inflammation with consequent bone loss and …

[HTML][HTML] Reducing the risk of mortality in chronic obstructive pulmonary disease with pharmacotherapy: A narrative review

M Mintz, I Barjaktarevic, DA Mahler, B Make… - Mayo Clinic …, 2023 - Elsevier
In 2020, chronic obstructive pulmonary disease (COPD) was the fifth leading cause of death
in the United States excluding COVID-19, and its mortality burden has been rising since the …

Effect of fracture risk in inhaled corticosteroids in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis

S Peng, C Tan, L Du, Y Niu, X Liu, R Wang - BMC Pulmonary Medicine, 2023 - Springer
Background The fracture risk of patients with chronic obstructive pulmonary disease (COPD)
treated with inhaled corticosteroids is controversial. And some large-scale randomized …

Advances in inhaled corticosteroids for the treatment of chronic obstructive pulmonary disease: what is their value today?

M Cazzola, J Ora, L Calzetta, P Rogliani… - Expert Opinion on …, 2022 - Taylor & Francis
Introduction As of today, there is still a need to determine which COPD patients may benefit
from ICS therapy, whether ICSs are useful in COPD patients without chronic bronchitis, and …

Inhaled Corticosteroids in Subjects with Chronic Obstructive Pulmonary Disease: An Old, Unfinished History

AS Melani, S Croce, G Fabbri, M Messina, E Bargagli - Biomolecules, 2024 - mdpi.com
Chronic obstructive pulmonary disease (COPD) is one of the major causes of disability and
death. Maintenance use of inhaled bronchodilator (s) is the cornerstone of COPD …

[PDF][PDF] The role of lncRNA in the pathogenesis of chronic obstructive pulmonary disease

J Xie, Y Wu, Q Tao, H Liu, J Wang, C Zhang, Y Zhou… - Heliyon, 2023 - cell.com
Chronic obstructive pulmonary disease (COPD) is characterized by progressive and
irreversible airflow obstruction with abnormal lung function. Because its pathogenesis …

[PDF][PDF] Efficiency and safety of baofei granules in chronic obstructive pulmonary disease (lung and spleen qi deficiency syndrome): a multicenter, randomized, double …

Y Sun, X Chen, L Zhang, W Yuan, Q Chen… - Drug Design …, 2022 - Taylor & Francis
Background Baofei Granules (BFGs) have been extensively applied in the clinical treatment
of chronic obstructive pulmonary disease (COPD) and significantly have affected COPD …